Experiences of using vedolizumab in the East Midlands, United Kingdom: A retrospective observational study

First published 22/05/2018

Last updated 23/04/2024

EU PAS number:

EUPAS23658

Study

Finalised

Download as PDF

Documents

Study protocol

Study results

Study results

Vedolizumab-5049 - Synopsis - _FINAL_V1 1_31JUL2019

English (711.73 KB - PDF)View document

Vedolizumab-5049_Synopsis_Redacted

English (794.32 KB - PDF)View document

Study report

Other information